Literature DB >> 34775677

The performance of glycated albumin as a biomarker of hyperglycemia and cardiometabolic risk in children and adolescents in the United States.

Amelia S Wallace1,2, Mary R Rooney1,2, Tammy M Brady3, Justin B Echouffo-Tcheugui4, Robert Christenson5, Morgan E Grams1,2,4, Elizabeth Selvin1,2.   

Abstract

OBJECTIVE: Diabetes and prediabetes are growing concerns among US youth. Fasting glucose (FG) and HbA1c are standard diabetes screening tests, but HbA1c may be unreliable in some settings and fasting is burdensome in children. Glycated albumin (GA) is a non-fasting test that was recently cleared for clinical use in the United States, but studies in youth without diabetes are limited. RESEARCH DESIGN AND METHODS: We conducted a cross-sectional analysis in 6826 youth without diabetes aged 8-19 years in the 1999-2004 National Health and Nutrition Examination Survey. We evaluated the associations of GA with HbA1c, FG, and cardiometabolic risk factors.
RESULTS: GA was poorly correlated with HbA1c (ρ = 0.074) and FG (ρ = -0.047) and was negatively associated with body mass index (BMI) and cardiometabolic risk factors. Compared to youth in the highest tertile of GA (≥13.5%), those in the lowest GA tertile (<12.4%) had a higher prevalence of obesity (29.9% vs. 7.6%), low high-density lipoprotein cholesterol (29.7% vs. 16.5%), and hypertensive blood pressure (4.0% vs. 2.7%). These inverse associations persisted after adjustment for age, sex, race/ethnicity, serum albumin, and C-reactive protein.
CONCLUSIONS: GA was poorly correlated with traditional markers of hyperglycemia in youth without diabetes. Counterintuitively, there was a negative association between GA and BMI. Among youth without diabetes, GA does not identify youth at high cardiometabolic risk, and it does not appear to be an appropriate biomarker for screening of hyperglycemia.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adolescents; cardiometabolic risk factors; diagnostic tests; glycated albumin; hyperglycemia

Mesh:

Substances:

Year:  2021        PMID: 34775677      PMCID: PMC8844057          DOI: 10.1111/pedi.13281

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  47 in total

1.  Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report.

Authors: 
Journal:  Pediatrics       Date:  2011-11-14       Impact factor: 7.124

2.  Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.

Authors:  Christine L Chan; Laura Pyle; Megan Kelsey; Lindsey Newnes; Philip S Zeitler; Kristen J Nadeau
Journal:  Pediatr Diabetes       Date:  2015-02-05       Impact factor: 4.866

Review 3.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021.

Authors: 
Journal:  Diabetes Care       Date:  2021-01       Impact factor: 19.112

4.  Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.

Authors:  Elizabeth Selvin; Andreea M Rawlings; Pamela L Lutsey; Nisa Maruthur; James S Pankow; Michael Steffes; Josef Coresh
Journal:  Circulation       Date:  2015-05-28       Impact factor: 29.690

5.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

6.  Screening for type 2 diabetes in obese youth.

Authors:  Shuchi Shah; Bassil M Kublaoui; Jon D Oden; Perrin C White
Journal:  Pediatrics       Date:  2009-07-20       Impact factor: 7.124

7.  Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.

Authors:  Linda J Andes; Yiling J Cheng; Deborah B Rolka; Edward W Gregg; Giuseppina Imperatore
Journal:  JAMA Pediatr       Date:  2020-02-03       Impact factor: 16.193

8.  Normative Values of High-Sensitivity Cardiac Troponin T and N-Terminal pro-B-Type Natriuretic Peptide in Children and Adolescents: A Study from the CALIPER Cohort.

Authors:  Emily Lam; Victoria Higgins; Liyong Zhang; Man Khun Chan; Mary Kathryn Bohn; Karin Trajcevski; Peter Liu; Khosrow Adeli; Paul C Nathan
Journal:  J Appl Lab Med       Date:  2021-03-01

9.  Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Mary R Rooney; Olive Tang; James S Pankow; Elizabeth Selvin
Journal:  Diabetologia       Date:  2020-09-29       Impact factor: 10.122

Review 10.  Hypoalbuminemia: Pathogenesis and Clinical Significance.

Authors:  Peter B Soeters; Robert R Wolfe; Alan Shenkin
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-10-04       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.